El peor estado de salud imaginable
El mejor estado de salud imaginable
Su estado de salud HOY
Para ayudar a la gente a describir lo bueno o malo que es su estado de salud en una escala parecida a un termómetro en el cual se marca con un 100 el mejor estado de salud que pueda imaginarse y con un 0 el peor estado de salud que pueda imaginarse.
Nos gustaría que nos indicara en esta escala, en su opinión, lo bueno y malo que es su estado de salud en el día de HOY. Por favor, dibuje una línea desde el casillero donde dice
“Su estado de salud hoy” hasta el punto del termómetro que en su opinión indique lo bueno o malo que es su estado de salud en el día de HOY.
191
11. BIBLIOGRAFÍA
192
11.BIBLIOGRAFÍA
1. Froriep R. Ein beitrag zur pathologie und therapie des rheumatismus. 1843.Weimar.
2. Gowers WR. Lumbago: its lessons and analogues. Br Med J .1904, 1: 117-21.
3. Elliot.Volume 244Number 6310p165-196.1944.
4. Kelly M. The nature of fibrositis. Ann Rheum Dis. 1946. 5:69-77, 1.
5. Kraft GH, Johnson EW, La Ban MM. The fibrositis syndrome. Arch Phys Med Rehabil. 1968; 49(3):155-62.
6. Smythe HA, Moldofsky H. Two contributions to understanding of the"fibrositis"
syndrome. Bull Rheum Dis. 1977; 28: 928-31.
7.Yunus MB, Masi, AT, Calabro JJ, Miller KA, Feigenbaum SL. Primary fibromyalgia (fibrositis): a clinical study of 50 patients with matched controls. Seminars in Arthritis and Rheumatism; 1981. 11:151-71.
8. Campbell, AJ, Borrie MJ, Spears GF. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol. 1989; 44: M112–7.
9. Yunus MB, Masi AT, Aldag JC. Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutiveseries of PFS, other pain patients, and normal subjects. Clinical and Experimental Rheumatology; 1989. 7:63–9.
10. Golbernberg DA. Prospective evaluation of 118 patients with fibromyalgia syndrome:
prevalence of Raynaud’s phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction. The Journal Rheumatology; 1986. 13 (2):
368-373.
11. McCarthy DJ, Csuka M, McCarthy et al. Treatment of pain due to fibromyalgia with topical capsaicin: A pilot study. Semin Arthritis Rheum. 1994; 23(suppl 3):41 – 47.
12. Jain AK, Carruthers BM, van de Sande MI, Barron SR, Donaldson CCS, Dunne JV, et al. Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocol a consensus document. J Musculoskeletal Pain. 2003; 11(4):3–107.
193 13. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence based
recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis.2008.
67, 536-41.
14. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fribromyalgia and measurement of symptom severity. Arthritis Care Res.; 2010. 62 (5): 600-10.
15. Arnold, LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of Fibromyalgia. Mayo Clin Proc. 2011; 86(5): 457- 464.
16. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr. Family study of fibromyalgia. Arthritis and Rheumatism. 2004.;50(3):944-52 DOI:10.1002/art.20042.
17. Valverde M. Prevalencia de la fibromialgia en la población española. Estudio EPISER.
Rev Esp Reumatol; 2000. 27:157.
18. Buskila D. The developement of widespread pain after injures. J Musculo Skel Pain;
2002. 10:261.
19. Ubago-Linares MC, Ruiz-Pérez I, Bermejo-Pérez MJ, Olry de Labry-Lima A y Plazaola-Castaño J. Características clínicas y psicosociales de personas con fibromialgia.
Repercusión del diagnóstico sobre sus actividades. Rev. Esp. Salud Publica 2005. v.79 n.6 Madrid.
20.Kalyan-Raman, U.P., Kalyan-Raman, K., Yunus, M.B., Masi, A.T. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol. 1984; 11(6):808–813.
21.Bartels EM, Danneskiold-Samsoe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet.1986; 1(8484):755–757.
22.Bengtsson A, Henriksson KG y Larsson J. Reduced high-energy pshospahte levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum. 1986. 29, 817- 21.
23. Bengtsson A, Henriksson KG. The muscle in fibromyalgia: a review of Swedish studies. The Journal of Rheumatology. 1989.Supplement.;19:144-9.
194 24.Larsson NG, Tulinius MH, Holme E, Oldfors A, Andersen O, Wahlström J, Aasly J.
Segregation and manifestations of the mtDNA tRNA (Lys) A-->G (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Ann J Hum Genet. 1992;
51(6):1201-12.
25. Bengtsson U, Altherr MR, Wasmuth JJ, Winokur ST. High resolution fluorescence in situ hybridization to linearly extended DNA visually maps a tandem repeat associated with facioscapulohumeral muscular dystrophy immediately adjacent to the telomere of 4q. Hum Mol Genet. 1994; 3(10):1801-5.
26. Jacobsen S, Danneskiold-Samsoe B, Anderson RE. Sadenosyl-methionine in primary fibromyalgia: double-blind clinical evaluation. Scand J Rheumatol. 1991; 20: 294-302.
27. Park VM, Pivnick EK. Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet. 1998;35(10):813-20.
28. Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci. 1998; 315(6):346-50.
29. Bengtsson A, Bengtsson M. Regional sympathetic blockade in primary fibromyalgia.
Pain. 1988; 33(2):161-7.
30. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 y before clinical diagnosis. Diabetes Care. 1992; 15(7):815-9.
31. Russell RG, Graveley R, Coxon F, Skjodt H, Del Pozo E, Elford P, Mackenzie A.
Cyclosporin A. Mode of action and effects on bone and joint tissues. Scand J Rheumatol Suppl. 1992; 95: 9-18.
32. Moldofsky H, Wong MTH, Lue FA. Litigation, sleep, symptoms and disabilities in postaccident pain (fibromyalgia syndrome). J Rheumatol 1993, 20, 1935-41.
33. Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, Müller W.
Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis. Med Klin (Munich). 1993; 88(8):458-62.
34. Yunus MB, AIdag IC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ Clinical Research ed.; 1996. 312: 1339.
195 35. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty -five-year follow-up of the seven countries study. JAMA. 1995; 274(2):131-6.
36. Bennett RM, Burckhardt CS, Clark SR et al. Group treatment of fibromyalgia: a 6-month outpatient program. J Rheumatol 1996; 23: 521-8.
37. Griep EN, Boersma JW, De Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol. 1993; 20(3):469-74.
38. Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome.Ann N Y Acad Sci. 1998; 840:684-97.
39. Bennett R, Russell IJ, Choy E, Spaeth M, Mease P, Kajdasz D et al. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine. A. Clin Ther. 2012; 34(4):824-37.
40. Leal-Cerro A, Povedano J, Astorga R, Gonzalez M, Silva H, Garcia-Pesquera F et al.
The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J. Clin Endocrinol Metab. 1999; 84(9):3378-81.
41. Offenbaecher M, Ackenheil M. Current trends in neuropathic pain treatments with special reference to fibromyalgia. CNS Spectr. 2005; 10(4):285-97.
42. Russell AJ, Wallace AM, Forest MG, Donaldson MD, Edwards CR, Sutcliffe
RGMutation in the human gene for 3 beta-hydroxysteroid dehydrogenase type II leading to male pseudohermaphroditism without salt loss. J Mol Endocrinol. 1994; 12(2):225-37.
43. Buskila D, Press J, Gedalia, A, Klein M, Neumann L, Boehm R, Sukenik S.
Assessment of nonarticular tenderness and prevalence of fibromyalgia in children. J Rheumatol; 1993. 20: 368-70.
44. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidente of Raynaud phenomenon in patients with fibromialgia: new features for diagnosis. Pain, 1988;(1):21-6.
196 45. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Henri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L. Severe hepatic fibrosis in
Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet. 1999; 65(3):709-21.
46. Ohlin E, FrancardoV, Lindgren H, Sillivan E, O’Sullivan S, Luksik A, Vassoler F, Lees, Konradi K, Cenci A. Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain. 2011;
134(8): 2339–2357.19. doi: 10.1093/brain/awr165.
47. Halling-Sorensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten Lützhoft HC, Jorgensen SE. Occurrence, fate and effects of pharmaceutical substances in the environment a review. Chemosphere. 1998; 36(2):357-93.
48. Hudson JI, Pope Jr HG. The relationship between fibromyalgia and major depressive disorder. Rheumatic Disease Clinics of North America, 1996. 22, 285–303.
49. Goldenberg DL. Fibromyalgia syndrome: an emerging but controversial condition.
JAMA; 1987. 257: 2782-7.
50. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G et al. Lactate provocation of panic attacks. II. Biochemical and physiological findings. 1986.
51. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism.; 1995. 38:19-28.
52. Ahles TA, Blanchard EB, Ruckdeschel JC. The multidimensional nature of cancer related pain. Pain. 1983. 17(3):277–288.
53. Walker JT, Burnett CA, Lalich NR, Sestito JP, Halperin WE. Cancer mortality among laundry and dry cleaning workers. Ann J Ind Med. 1997; 32(6):614-9.
54. Strong EW, Batsakis JG, Cassisi NJ et al. Head and neck sites. in: AJCC Cancer Staging Manual. (5th ed.). Lippincott-Raven, Philadelphia, PA; 1997:21–58.
55. Eisendrath SJ. Psychiatric aspects of chronic pain. Neurology. 1995; 45(12 Suppl 9):
S26-34; discussion S35-6.
197 56. Blécourt AC, Wolf RF, Van Rijswijk MH, Kamman RL, Knipping AA, Mooyaart EL.
In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome. Rheumatol Int. 1991; 11(2):51–54.
57. Staud R. Fibromyalgia pain: do we know the source? Curr Opin Rheumatol. 2004; 16:
157-63.
58. Martínez-Lavin M, Infante O, Lerma C. Hypothesis: the chaos and complexity theory may help our understanding of fibromyalgia and similar maladies. Semin Arthritis Rheum, 2008. 37(4), 260-4.
59. Kroenke K, Price RK. Symptoms in the community. Prevalence, classification and psychiatric comorbidity. Arch Intern Med. 1993. 153: 2474-80.
60. Campbell SM, Ludt S, Van Lieshout J, Boffin N, Wensing M, Petek D, Grol R, Roland MO. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries. Eur J Cardiovasc Prev Rehabil. 2008; 15(5):509-15. doi: 10.1097/HJR.0b013e328302f44d.
61. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many.
Lancet 1999; 354: 936 –9.
62. Arnold L. The Pathophysiology. Diagnosis and Treatment of Fibromyalgia. Psychiatr Clin North Am. 2010; 33: 375-408.
63. Moldofsky H. Chrono-biological influences on fibromyalgia syndrome: theoretical and therapeutic implications. Baillieres Clin Rheumatol; 1994. 8:801- 810.
64. Rizzi M, Spanghero S, Fontana A, Obersnu F, Ginanneschi U. Von Recklinhausen's disease and interstinal neurofibromatosis: a case report. Chir Ital 2003; 55: 261-5.
65. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis and Rheumatism, 2001. 44, 222- 230.
66. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms.
Physiol Rev. 2008 ; 88(1):287-332. doi: 10.1152/physrev.00015.2007.
67. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. Restless Legs Syndrome Task Force of the Standards of Practice Committee of the American Academy of Sleep
198 Medicine.An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep. 2004; 27(3):560-83.
68. Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ. Profile of altered brain iron acquisition in restless legs syndrome. Brain. 2011; 134(Pt4):959-68. doi:
10.1093/brain/awr 012.
69. Burckhardt C, Clark S, Bennet R. The Fibromyalgia Impact Questionnaire:
development and validation. Journal of Rheumatology. 1991, 18, 728-733.
70. Littlejohn C, Hilton S, Macfarlane GJ, Phull P. Systematic review and meta-analysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cancer. Br J Surg. 2012; 99(11):1488-500. doi: 10.1002/bjs.8882.
71. Suhr JA. Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res. 2003; 55(4):321-9.
72. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ.
Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain; 2003.
102(3):243-50.
73. Tischler L, Brand SR, Stavitsky K, Labinsky E, Newmark R, Grossman R, Buchsbaum MS, Yehuda, R. The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD. Ann N Y Acad Sci. 2006;
1071:405-9.
74. Lutz J, Jäger L, De Quervain D, Krauseneck T, Padberg F, Wichnalek M, Beyer A, Stahl R, Zirngibl B, Morhard D, Reiser M, Schelling G. White and gray matter
abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 2008; 58(12):3960-9. doi: 10.1002/art.24070.
75. Luerding R, Weigand T, Bogdahn U, Schmidt-Wilcke T. Working memory
performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition
interaction. Brain. 2008; 131(Pt 12):3222-31. doi: 10.1093/brain/awn229.
76. Martínez-Lavin M. Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol, 2001. 19(1), 1-3.
199 77. Jones KD, Horak FB, Winters-Stone K, Irvine JM, Bennett RM. Fibromyalgia is associated with impaired balance and falls. J Clin Rheumatol. 2009; 15(1):16-21. doi:
10.1097/RHU.0b013e318190f991.
78. Kratz AL, Davis MC, Zautra AJ. Pain acceptance moderates the relation between pain and negative affect in female osteoarthritis and fibromyalgia patients. Ann Behav Med.
2007; 33(3):291-301.
79. Rutledge DN, Jones K, Jones CJ. Predicting high physical function in people with fibromyalgia. J Nurs Scholarsh. 2007; 39(4):319-24.
80. Keene KL, Mychaleckyj JC, Leak TS, Smith SG, Perlegas PS, Divers J, Langefeld CD, Freedman BI, Bowden DW. Scale MMExploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet. 2008; 124(2):147-54. Doi:
10.1007/s00439-008-0532-6.
81. Ostuni A, Castiglione, Morelli MA, Miglionico R, Salvia AM, Cuviello F, Bisaccia F.
Expression, purification and structural characterization of up-regulated gene 7 encoded protein. Protein Pept Lett. 2014; 21(5):413-8.
82. Bohrmann J, Bonafede A. Tissue-specific distribution and variation of the channel-forming protein ductin during development of Drosophila melanogaster. Int J Dev Biol.
2000 Dec; 44(8):883-90. Erratum in: Int J Dev Biol .2001; 45(4):695, 883-6.
83. Orellana C, Gratacós J, Galisteo C, Larrosa M. Sexual dysfunction in patients with fibromyalgia. Curr Rheumatol Rep. 2009; 11(6):437-42.
84. Hughes RB, Robinson-Whelen S, Taylor HB, Hall JW. Stress self-management: an intervention for women with physical disabilities. Womens Health Issues. 2006; 16 (6):389-99.
85. Peres JF, Gonçalves AL, Peres MF. Psychological trauma in chronic pain: implications of TEPT for fibromyalgia and headache disorders. Curr Pain Headache Rep. 2009;
13(5):350-7.
86. Thieme K, Turk DC, Flor H. Responder criteria for operant and cognitive-behavioral treatment of fibromyalgia syndrome. Arthritis Rheum, 2007.57(5), 830-6.